secwatch.observer — SEC 8-K summary
======================================

Issuer:     UroGen Pharma Ltd. (URGN)
CIK:        0001668243
Form:       8-K
Filed at:   2024-09-13T23:59:59+00:00
Accession:  0001193125-24-218868
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Fred E. Cohen resigns from UroGen Pharma board effective immediately
-----------------------------------------------------------------------------

- Fred E. Cohen resigned as director on Sept 12, 2024.
- Resignation is not due to any disagreement with the company.
- No replacement director has been announced.
- Dr. Cohen's departure is effective immediately.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1668243/000119312524218868/0001193125-24-218868-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1668243/000119312524218868/d851871d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-218868

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer